Advances in Host-Directed Therapies Against Tuberculosis
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Springer International Publishing

9783030569044, 9783030569051

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Autophagy as a Target for Host-Directed Therapy Against Tuberculosis

Advances in Host-Directed Therapies Against Tuberculosis ◽

10.1007/978-3-030-56905-1_6 ◽

2020 ◽

pp. 71-95

Author(s):

Surbhi Verma ◽

Raman Deep Sharma ◽

Dhiraj Kumar

Download Full-text

The Mammalian Target of Rapamycin Complex 1 (mTORC1): An Ally of M. tuberculosis in Host Cells

Advances in Host-Directed Therapies Against Tuberculosis ◽

10.1007/978-3-030-56905-1_3 ◽

2020 ◽

pp. 27-40

Author(s):

Natalie Bruiners ◽

Valentina Guerrini ◽

Maria Laura Gennaro

Keyword(s):

Mammalian Target Of Rapamycin ◽

Host Cells ◽

Target Of Rapamycin

Download Full-text

Pharmacological Considerations for Clinical Trials of Host-Directed Therapies for Tuberculosis

Advances in Host-Directed Therapies Against Tuberculosis ◽

10.1007/978-3-030-56905-1_22 ◽

2020 ◽

pp. 311-332

Author(s):

Elisa H. Ignatius ◽

Kelly E. Dooley

Keyword(s):

Clinical Trials

Download Full-text

C3HeB/FeJ as a Key Mouse Strain for Testing Host-Directed Therapies Against Tuberculosis

Advances in Host-Directed Therapies Against Tuberculosis ◽

10.1007/978-3-030-56905-1_18 ◽

2020 ◽

pp. 267-273

Author(s):

Pere-Joan Cardona ◽

Cristina Vilaplana

Keyword(s):

Mouse Strain

Download Full-text

In Vitro Models of Human Granuloma Formation to Analyze Host-Directed Therapies

Advances in Host-Directed Therapies Against Tuberculosis ◽

10.1007/978-3-030-56905-1_17 ◽

2020 ◽

pp. 259-265

Author(s):

Liku B. Tezera ◽

Michaela T. Reichmann ◽

Basim Al Shammari ◽

Paul T. Elkington

Keyword(s):

In Vitro Models ◽

Granuloma Formation

Download Full-text

Alveolar Epithelial Cells

Advances in Host-Directed Therapies Against Tuberculosis ◽

10.1007/978-3-030-56905-1_16 ◽

2020 ◽

pp. 247-255

Author(s):

Angélica M. Olmo-Fontánez ◽

Jordi B. Torrelles

Keyword(s):

Epithelial Cells ◽

Alveolar Epithelial Cells ◽

Alveolar Epithelial

Download Full-text

Type I Interferon and Interleukin-1 Driven Inflammatory Pathways as Targets for HDT in Tuberculosis

Advances in Host-Directed Therapies Against Tuberculosis ◽

10.1007/978-3-030-56905-1_14 ◽

2020 ◽

pp. 219-232

Author(s):

Katrin D. Mayer-Barber ◽

Christopher M. Sassetti

Keyword(s):

Type I Interferon ◽

Interleukin 1 ◽

Type I ◽

Inflammatory Pathways

Download Full-text

Metformin: A Leading HDT Candidate for TB

Advances in Host-Directed Therapies Against Tuberculosis ◽

10.1007/978-3-030-56905-1_7 ◽

2020 ◽

pp. 97-108

Author(s):

Amit Singhal ◽

Hardy Kornfeld

Download Full-text

Nuclear Receptors in Host-Directed Therapies against Tuberculosis

Advances in Host-Directed Therapies Against Tuberculosis ◽

10.1007/978-3-030-56905-1_5 ◽

2020 ◽

pp. 61-67

Author(s):

Eun-Kyeong Jo

Keyword(s):

Nuclear Receptors

Download Full-text

Outcomes for Clinical Trials of Host-Directed Therapies for Tuberculosis

Advances in Host-Directed Therapies Against Tuberculosis ◽

10.1007/978-3-030-56905-1_21 ◽

2020 ◽

pp. 295-310

Author(s):

Akshay N. Gupte ◽

Sara C. Auld ◽

William N. Checkley ◽

Gregory P. Bisson

Keyword(s):

Clinical Trials

Download Full-text

Advances in Host-Directed Therapies Against TuberculosisLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer International Publishing

Autophagy as a Target for Host-Directed Therapy Against Tuberculosis

The Mammalian Target of Rapamycin Complex 1 (mTORC1): An Ally of M. tuberculosis in Host Cells

Pharmacological Considerations for Clinical Trials of Host-Directed Therapies for Tuberculosis

C3HeB/FeJ as a Key Mouse Strain for Testing Host-Directed Therapies Against Tuberculosis

In Vitro Models of Human Granuloma Formation to Analyze Host-Directed Therapies

Alveolar Epithelial Cells

Type I Interferon and Interleukin-1 Driven Inflammatory Pathways as Targets for HDT in Tuberculosis

Metformin: A Leading HDT Candidate for TB

Nuclear Receptors in Host-Directed Therapies against Tuberculosis

Outcomes for Clinical Trials of Host-Directed Therapies for Tuberculosis

Advances in Host-Directed Therapies Against Tuberculosis
Latest Publications